These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26188123)

  • 1. The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors.
    Fazi B; Felsani A; Grassi L; Moles A; D'Andrea D; Toschi N; Sicari D; De Bonis P; Anile C; Guerrisi MG; Luca E; Farace MG; Maira G; Ciafré SA; Mangiola A
    Oncotarget; 2015 Sep; 6(26):22526-52. PubMed ID: 26188123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
    Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
    OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma.
    Tomaselli S; Galeano F; Alon S; Raho S; Galardi S; Polito VA; Presutti C; Vincenti S; Eisenberg E; Locatelli F; Gallo A
    Genome Biol; 2015 Jan; 16(1):5. PubMed ID: 25582055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.
    Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C
    Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain.
    Geisenberger C; Mock A; Warta R; Rapp C; Schwager C; Korshunov A; Nied AK; Capper D; Brors B; Jungk C; Jones D; Collins VP; Ichimura K; Bäcklund LM; Schnabel E; Mittelbron M; Lahrmann B; Zheng S; Verhaak RG; Grabe N; Pfister SM; Hartmann C; von Deimling A; Debus J; Unterberg A; Abdollahi A; Herold-Mende C
    Acta Neuropathol; 2015 Sep; 130(3):419-34. PubMed ID: 25931051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
    Burton EC; Lamborn KR; Forsyth P; Scott J; O'Campo J; Uyehara-Lock J; Prados M; Berger M; Passe S; Uhm J; O'Neill BP; Jenkins RB; Aldape KD
    Clin Cancer Res; 2002 Jan; 8(1):180-7. PubMed ID: 11801556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
    Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
    Zhang S; Lai N; Liao K; Sun J; Lin Y
    Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
    Wang G; Wang JJ; Tang HM; To SS
    Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma.
    Darmanis S; Sloan SA; Croote D; Mignardi M; Chernikova S; Samghababi P; Zhang Y; Neff N; Kowarsky M; Caneda C; Li G; Chang SD; Connolly ID; Li Y; Barres BA; Gephart MH; Quake SR
    Cell Rep; 2017 Oct; 21(5):1399-1410. PubMed ID: 29091775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma multiforme: Metabolic differences to peritumoral tissue and IDH-mutated gliomas revealed by mass spectrometry imaging.
    Kampa JM; Kellner U; Marsching C; Ramallo Guevara C; Knappe UJ; Sahin M; Giampà M; Niehaus K; Bednarz H
    Neuropathology; 2020 Dec; 40(6):546-558. PubMed ID: 32662157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells.
    Guo P; Nie Q; Lan J; Ge J; Qiu Y; Mao Q
    Biochem Biophys Res Commun; 2013 Nov; 441(1):186-90. PubMed ID: 24140063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities.
    Stevenson CB; Ehtesham M; McMillan KM; Valadez JG; Edgeworth ML; Price RR; Abel TW; Mapara KY; Thompson RC
    Neurosurgery; 2008 Sep; 63(3):560-9; discussion 569-70. PubMed ID: 18812968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.
    Zhang W; Shen C; Li C; Yang G; Liu H; Chen X; Zhu D; Zou H; Zhen Y; Zhang D; Zhao S
    Mol Carcinog; 2016 May; 55(5):575-85. PubMed ID: 25764520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
    Wang G; Wang J; Zhao H; Wang J; Tony To SS
    Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
    Gao X; Jin W
    Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
    Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
    Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.